Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR).

Saved in:
Bibliographic Details
Title: Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR).
Authors: Monsellato, Igor1 (AUTHOR) igor.monsellato@ospedale.al.it, Alongi, Filippo2 (AUTHOR), Bertocchi, Elisa2 (AUTHOR), Gori, Stefania2 (AUTHOR), Ruffo, Giacomo2 (AUTHOR), Cassinotti, Elisa3 (AUTHOR), Baldarti, Ludovica3 (AUTHOR), Boni, Luigi3 (AUTHOR), Pernazza, Graziano4 (AUTHOR), Pulighe, Fabio5 (AUTHOR), De Nisco, Carlo5 (AUTHOR), Perinotti, Roberto6 (AUTHOR), Morpurgo, Emilio7 (AUTHOR), Contardo, Tania8 (AUTHOR), Mammano, Enzo7 (AUTHOR), Elmore, Ugo9 (AUTHOR), Delpini, Roberto9 (AUTHOR), Rosati, Riccardo9 (AUTHOR), Perna, Federico10 (AUTHOR), Coratti, Andrea10 (AUTHOR)
Source: BMC Cancer. 12/16/2019, Vol. 19 Issue 1, p1-7. 7p. 1 Diagram.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-019-6271-3